Viking Therapeutics, Inc. VKTX
2 trading plans running, 7 Form 144 notices for $18.3M
10-Q, 10-K and Form 144What VKTX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Jan 15, 2026 to Dec 8, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Charles A. Rowland Director |
Adopted 10b5-1 plan | Sep 4, 2026 | 10-Q Oct 29, 2026 |
| J. Matthew Singleton Director |
Ended 10b5-1 plan | Aug 14, 2026 | 10-Q Jul 24, 2024 |
| Marianne Mancini Chief Operations Officer |
Ended 10b5-1 plan | Feb 16, 2026 | 10-Q Apr 24, 2025 |
| Brian Lian Chief Executive Officer |
Adopted 10b5-1 plan | Jan 15, 2026 | 10-Q Apr 30, 2026 |
| Brian Lian Chief Executive Officer |
Ended 10b5-1 plan | Dec 31, 2025 | 10-Q Apr 24, 2025 |
| Lawson Macartney Director |
Ended 10b5-1 plan | Sep 30, 2025 | 10-K Feb 26, 2025 |
| Sarah K. Rouan Director |
Ended 10b5-1 plan | Aug 19, 2025 | 10-Q Jul 24, 2024 |
| Brian Lian President, Chief Executive Officer and Director |
Ended 10b5-1 plan | Aug 8, 2025 | 10-Q Jul 24, 2024 |
| Marianne Mancini Chief Operations Officer |
Ended plan | Apr 20, 2025 | 10-Q Apr 25, 2024 |
| Greg Zante Chief Financial Officer |
Ended 10b5-1 plan | Mar 31, 2025 | 10-Q Oct 23, 2024 |
| Lawson Macartney, Ph.D Director |
Ended 10b5-1 plan | Feb 21, 2025 | 10-Q Jul 24, 2024 |
| Greg Zante Chief Financial Officer |
Ended plan | Aug 1, 2024 | 10-Q Apr 25, 2024 |
Show the other 4 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 26, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Jul 29, 2026 | BRIAN LIAN Officer |
148,517 | $4.9M |
| Jul 29, 2026 | GREG ZANTE Officer |
21,217 | $710K |
| Jul 29, 2026 | MARIANNA MANCINI Officer |
18,217 | $610K |
| Jan 5, 2026 | MARIANNA MANCINI Officer |
57,661 | $1.9M |
| Jan 5, 2026 | GREG ZANTE Officer |
57,661 | $1.9M |
| Jan 5, 2026 | BRIAN LIAN Officer |
233,409 | $7.7M |
| Jan 2, 2026 | MATTHEW W. FOEHR Director |
16,000 | $562K |
From the Form 144 XML filed with the SEC, since Jan 2, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VKTX/export.csv") into a cell.